Pacific Biosciences Of California - 14 Year Stock Price History | PACB

Historical daily share price chart and data for Pacific Biosciences Of California since 2010 adjusted for splits and dividends. The latest closing stock price for Pacific Biosciences Of California as of May 23, 2024 is 1.94.
  • The all-time high Pacific Biosciences Of California stock closing price was 51.15 on February 11, 2021.
  • The Pacific Biosciences Of California 52-week high stock price is 14.55, which is 650% above the current share price.
  • The Pacific Biosciences Of California 52-week low stock price is 1.25, which is 35.6% below the current share price.
  • The average Pacific Biosciences Of California stock price for the last 52 weeks is 7.95.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pacific Biosciences Of California Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 4.4271 9.5900 9.5900 1.3600 1.9400 -80.22%
2023 10.4204 7.9400 14.0500 5.9700 9.8100 19.93%
2022 7.9703 20.9000 20.9000 3.9250 8.1800 -60.02%
2021 29.3971 26.3750 51.1500 19.2600 20.4600 -21.13%
2020 7.6059 5.1600 28.5000 2.3600 25.9400 404.67%
2019 6.2150 7.4000 7.4100 4.6000 5.1400 -30.54%
2018 4.0056 2.7900 7.8200 2.0500 7.4000 180.30%
2017 4.1788 4.3600 5.5700 2.5900 2.6400 -30.53%
2016 8.6401 13.1900 13.1900 3.8000 3.8000 -71.06%
2015 6.6356 7.8100 13.4500 3.6600 13.1300 67.47%
2014 5.7342 5.0700 7.8400 4.1300 7.8400 49.90%
2013 3.2431 1.8500 5.9800 1.8000 5.2300 207.65%
2012 2.4529 2.9500 5.0400 1.1000 1.7000 -39.29%
2011 9.4028 16.3000 16.3000 2.2800 2.8000 -82.40%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.504B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $225.518B 27.33
Intuitive Surgical (ISRG) United States $142.199B 85.66
Edwards Lifesciences (EW) United States $54.361B 35.38
DexCom (DXCM) United States $51.910B 78.63
Alcon (ALC) Switzerland $44.749B 32.07
IDEXX Laboratories (IDXX) United States $42.775B 50.14
IQVIA Holdings (IQV) United States $41.183B 23.89
STERIS (STE) Ireland $22.787B 26.63
Waters (WAT) United States $20.691B 30.41
SONOVA HOLDING (SONVY) Switzerland $18.917B 0.00
Hologic (HOLX) United States $17.459B 19.53
ShockWave Medical (SWAV) United States $12.540B 78.04
Fresenius Medical Care AG KGaA (FMS) Germany $12.235B 14.28
Sysmex ADR (SSMXY) Japan $10.844B 34.01
Teleflex (TFX) United States $10.037B 15.62
Globus Medical (GMED) United States $9.090B 26.65
Penumbra (PEN) United States $7.713B 87.65
Masimo (MASI) United States $6.721B 38.72
Glaukos (GKOS) United States $5.426B 0.00
TransMedics (TMDX) United States $4.511B 428.03
Integer Holdings (ITGR) United States $4.073B 24.61
PROCEPT BioRobotics (PRCT) United States $3.449B 0.00
Tandem Diabetes Care (TNDM) United States $3.319B 0.00
LivaNova (LIVN) United Kingdom $3.280B 19.48
Elekta AB (EKTAY) Sweden $3.078B 21.12
Inari Medical (NARI) United States $2.771B 0.00
Nihon Kohden (NHNKY) Japan $2.493B 21.08
RxSight (RXST) United States $2.285B 0.00
Integra LifeSciences Holdings (IART) United States $2.216B 9.66
Veracyte (VCYT) United States $1.653B 0.00
Alphatec Holdings (ATEC) United States $1.505B 0.00
Artivion (AORT) United States $0.991B 95.04
AVANOS MEDICAL, INC (AVNS) United States $0.935B 18.18
OPKO Health (OPK) United States $0.920B 0.00
Silk Road Medical (SILK) United States $0.878B 0.00
OrthoPediatrics (KIDS) United States $0.790B 0.00
Pulse Biosciences (PLSE) United States $0.659B 0.00
Paragon 28 (FNA) United States $0.653B 0.00
Mesa Laboratories (MLAB) United States $0.617B 20.94
SiBone (SIBN) United States $0.578B 0.00
IRadimed (IRMD) United States $0.551B 30.88
ORTHOFIX MEDICAL INC (OFIX) United States $0.547B 0.00
Nevro (NVRO) United States $0.360B 0.00
Treace Medical Concepts (TMCI) United States $0.331B 0.00
Tactile Systems Technology (TCMD) United States $0.307B 10.50
AxoGen (AXGN) United States $0.271B 0.00
Sight Sciences (SGHT) United States $0.261B 0.00
AngioDynamics (ANGO) United States $0.253B 0.00
908 Devices (MASS) United States $0.233B 0.00
NeuroPace (NPCE) United States $0.228B 0.00
EDAP TMS S.A (EDAP) France $0.223B 0.00
Delcath Systems (DCTH) United States $0.218B 0.00
Inogen (INGN) United States $0.204B 0.00
Atossa Genetics (ATOS) United States $0.192B 0.00
Alpha Tau Medical (DRTS) Israel $0.189B 0.00
CVRx (CVRX) United States $0.184B 0.00
ClearPoint Neuro (CLPT) United States $0.166B 0.00
Semler Scientific (SMLR) United States $0.165B 8.37
Accuray (ARAY) United States $0.152B 0.00
Yubo Biotech (YBGJ) China $0.110B 0.00
KORU Medical Systems (KRMD) United States $0.102B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.096B 20.10
Neuronetics (STIM) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Monogram Orthopaedics (MGRM) United States $0.063B 0.00
Vicarious Surgical (RBOT) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
Envoy Medical (COCH) United States $0.059B 0.00
SEP Acquisition (SEPA) United States $0.052B 0.00
DarioHealth (DRIO) United States $0.052B 0.00
Autonomix Medical (AMIX) United States $0.048B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
LENSAR (LNSR) United States $0.047B 0.00
ReWalk Robotics (LFWD) Israel $0.043B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Pixie Dust Technologies (PXDT) Japan $0.035B 0.00
Aspira Women's Health (AWH) United States $0.031B 0.00
T2 Biosystems (TTOO) United States $0.031B 0.00
Spectral AI (MDAI) United States $0.029B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.025B 0.00
Accelerate Diagnostics (AXDX) United States $0.023B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
NexGel (NXGL) United States $0.015B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.011B 0.00
Avinger (AVGR) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00